Johnson & Johnson Recalls 43 Million Over-the-Counter Drugs
Drug manufacturers Johnson & Johnson announced on January 14 that they were recalling 43 million packages of Tylenol, Benadryl, Sudafed, and Sinutab because of prior manufacturing problems, according to The New York Times. In addition, four million packages of Rolaids were recalled because of incomplete labels.
According to the company, no health problems have been reported with the recalled drugs and claim that consumers can continue to use the products. The products were recalled because of manufacturing issues in the past, like improper equipment cleaning systems.
This recall is the latest in a string of recalls for Johnson & Johnson. About 225 million bottles of their over-the-counter drugs were recalled last year, as well as approximately 288 million drug product units, which include items such as bottles, vials, and other objects. Johnson & Johnson claims that these recalls have been planned since last summer in order to make its operations comply with federal law. As a result of the overhaul, the company closed a plant in Pennsylvania temporarily and has hired consultants to look at its quality control procedures.
Although Johnson & Johnson allege that no one has been affected as a result of its latest drug recall, plenty of consumers have been injured in prior years by defective drugs, such as Fen Phen, Chantix, Levequinn, Cipro and Ortho Evra. Consumers who are injured by unsafe over-the-counter or prescription drugs may be entitled to compensation for their injuries.
If you have suffered serious side effects from an unsafe or recalled drug, you may be able to seek compensation for medical bills, lost wages, pain and suffering, and other damages. Contact a Missouri product liability attorney today at Page Law, LLC. Call 314-241-2273 for a free consultation about your case.
